News
A downtrend has been apparent in Inhibikase Therapeutics, Inc. (IKT) lately. While the stock has lost 15.4% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was ...
The Ikt Wireless Earbuds are on sale for just $15, which is a massive 88% discount from their original $130 price. Walmart shoppers praise these earbuds for everything from their sound quality to ...
Shares of Inhibikase Therapeutics, Inc. (IKT) have been struggling lately and have lost 6.6% over the past week. However, a hammer chart pattern was formed in its last trading session, which could ...
If you buy something via one of our links, we may earn a commission. The IKT A10 Bluetooth Wireless Earbuds are on sale for just $15 right now at Walmart, a phenomenal 88% discount on their normal ...
Inhibikase Therapeutics shares are trading higher by 50% during Wednesday's session. The company announced the pricing of an approximately $110 million private placement financing. Get stock ...
It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as ...
Inhibikase Therapeutics pivots to focus on IkT-001Pro for pulmonary arterial hypertension after risvodetinib's failure in Parkinson's disease, leveraging imatinib's prior data. The company is well ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results